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Abstract
Background: Chronic kidney disease (CKD) is a progressive and lifelong condition with multiple medical comorbidities.
Patients with CKD experience frailty more frequently and have lower health-related quality of life than do those
with other chronic diseases. The purpose of this study was to examine the prevalence of frailty and investigate
the contribution of frailty to quality of life in pre-dialysis CKD patients in Korea.
Methods: Using a cross-sectional survey design, data were collected at an outpatient CKD clinic in a general hospital
in Korea. The frailty criterion was modified from previous studies. The Short Form-36 Health Survey version 2 was used
to measure physical and mental component summary scores. Data were analyzed using chi-square, t-tests, and
hierarchical linear regression.
Results: Of the 168 CKD patients, 63 (37.5 %) were frail. Frail patients were significantly older and had lower physical
and mental quality of life than those who were non-frail. In hierarchical regression evaluating the influence of frailty on
physical and mental quality of life, the initial model was significantly improved when frailty was included. Frail patients
had lower physical and mental quality of life.
Conclusions: Frailty affected both physical and mental quality of life in pre-dialysis patients with CKD. More attention
should be paid to the potential role of early detection and prevention of frailty to improve patients’ quality of life.
Keywords: Frailty, Pre-dialysis patients, Quality of life
Background
As a progressive and lifelong condition with multiple
medical comorbidities, chronic kidney disease (CKD) is
a global concern, and it affects approximately 5.9 % of
the Korean population [1]. Frailty is defined as cumulative
declines across multiple physiologic symptoms including
muscle weakness, low gait speed, unintentional weight
loss, exhaustion, and low physical activity [2–4]. The con-
cept of frailty was developed in geriatric populations [4],
but patients with chronic disease also suffer from frailty.
In particular, CKD patients experience frailty more fre-
quently than do individuals with normal renal function [5]
and those with other chronic diseases such as cancer and
vascular disease [6]. The prevalence of frailty in CKD pa-
tients ranges from 7 % [7] to 42.6 % [8], and various fac-
tors, including protein energy wasting, anemia, acidosis,
and hormonal disturbances, are thought to be related to
frailty occurrence in CKD patients [9].
Frailty is associated with adverse outcomes in CKD
patients, such as increased risk of death [3, 6] and
hospitalization [10], which leads significant impairment in
health-related quality of life (HRQOL) [11, 12]. HRQOL of
CKD patients differs by disease stage. Pre-dialysis patients
with CKD have better HRQOL than do dialysis patients
[13] and end-stage CKD patients [14], but worse HRQOL
than normative adults [13] and those with other chronic
diseases such as chronic obstructive pulmonary disease,
asthma, and diabetes [14]. The separate influences of frailty
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and quality of life on CKD patients who are on dialysis
treatment is relatively well documented, but few studies
have examined both frailty and HRQOL. Further, little is
known about the influence of frailty on HRQOL in pre-
dialysis patients with CKD. The purpose of this study was
to compare the factors that influence frailty and to investi-
gate the contribution of frailty to the HRQOL of pre-
dialysis CKD patients in Korea.
Methods
Study procedure
A cross-sectional survey with a convenience sampling
method was used. The study was conducted at an out-
patient CKD clinic in a general hospital in Korea from
March to September 2014. The eligibility criteria for par-
ticipation were as follows: diagnosis of stages 2–4 CKD,
20 years of age or older, and the ability to read and
complete the questionnaire. To assess cognitive impair-
ment, the physician of the CKD clinic who saw the patient
on a regular basis conducted a primary screening to deter-
mine if the patient was cognitively able to participate in
the study and provided a list of eligible participants to a
research assistant. During the interview process, the re-
search assistant conducted secondary assessments to en-
sure that the respondents were not cognitively impaired
and were able to complete the questionnaires. In terms of
ethical considerations, Institutional Review Board approval
was received from the participating hospital prior to data
collection. The research assistant informed participants of
the purpose of the study and confidentiality. Participants
were also informed of their right to withdraw from the
study at any time, and written consent forms were col-
lected from participants. The research assistant helped
participants complete the questionnaires, and the ques-
tionnaire completion time was approximately 20–25 min.
Using G*power version 3.0, a total of 166 individuals were
estimated for multiple regression analysis with nine pre-
dictors at the alpha level of .05 and medium effect size of
.15. Questionnaires were completed by 170 participants
for a period of 6 months. After two individuals who failed
to complete all questions were excluded, a total of 168 re-
spondents were included in the final analysis.
Measures
Frailty
The criterion of frailty was derived from three studies [8,
10, 15] and was modified for the current study. A score
below 75 on the physical functioning scale of the Short
Form-36 Health Survey (SF-36) was used as a marker of
muscle weakness, while a score below 55 on the vitality
scale of the SF-36 was used as a cut-off point for exhaus-
tion. Patients who reported that they “almost never or
never” exercised were classified as being inactive. As op-
posed to previous studies [8, 10] that categorized
undernourishment as unintentional weight loss over
5 kg, we considered undernourishment as unintentional
weight loss over 3 kg, which was previously used in
Chinese elderly individuals [15]. With regard to weight
loss, we assumed that the criterion of weight loss that
was applied to the same ethnicity (i.e., Asian) would be
more appropriate and valid, as Asians generally have a
smaller build than Westerners [16]. Those who scored
less than 75 on the physical functioning scale of the SF-
36 were given 2 points, whereas those who scored less
than 55 on the vitality scale, were in the category of ex-
ercising almost never or never, and those with uninten-
tional weight loss over 3 kg were given 1 point each, for
a total of 5 possible points. Consistent with the criterion
used in Mansur et al.’s study [8], patients scoring over 3
were classified as being frail.
Health-related quality of life
HRQOL was assessed using the SF-36 version 2 question-
naire [17], which consists of 36 items with 8 subscales. For
the current study, two sets of scores, the physical compo-
nent summary (PCS) and mental component summary
(MCS),were used to measure HRQOL. The PCS score was
calculated based on physical functioning, role limitations
due to physical problems, body pain, and general health
perception, while the MCS score was calculated based on
role limitations due to emotional problems, social func-
tioning, mental health, and vitality. Higher scores on the
PCS and MCS indicate better HRQOL.
Demographic and clinical characteristics
Patients’ demographic characteristics were obtained using
a self-report questionnaire. Clinical characteristics includ-
ing cause of CKD; comorbidities of diabetes, hypertension,
or cardiovascular disease; blood pressure; blood urea ni-
trogen (BUN); creatinine; and hemoglobin level were col-
lected from medical records. The level of estimated
glomerular filtration rate (GFR) was calculated using
the original Modification of Diet in Renal Disease
(MDRD) formula [18]. Estimated GFR (eGFR) of 60–
89 mL/min/1.73 m2 indicated stage 2 CKD, eGFR of 30–
59 mL/min/1.73 m2 indicated stage 3 CKD, and eGFR of
15–29 mL/min/1.73 m2 indicated stage 4 CKD.
Based on the literature review, the variables of demo-
graphic and clinical characteristics related to frailty or
HRQOL were selected for regression analyses: age [5, 8, 19,
20], gender [8, 10, 21], comorbidities [3, 19], renal function
[3, 6, 7, 22], educational level and living arrangement [19,
23], employment status [24], and living with spouse [25].
Statistical analysis
Data were analyzed using PASW Statistics version 20
(SPSS Inc., Chicago, IL, USA). The chi-square test was
used to test the relationship between the categorical
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variables and the frailty versus non-frailty groups. For
continuous variables including age, BUN, creatinine, blood
pressure, hemoglobin level, PCS, and MCS, independent
t-tests were conducted to compare the mean differences
between the frail and non-frail groups. Hierarchical linear
regression was performed to identify the influence of
frailty on PCS and MCS. The initial model included gender,
age, education level, living with spouse, comorbidity with
hypertension, comorbidity with diabetes, employment sta-
tus, and eGFR. Then, frailty was added to the second model
to examine the contribution of frailty to the covariates of
the previous model on PCS and MCS.
Results
Demographics, clinical characteristics, and physical and
mental component scores between frailty and non-frailty
groups
Table 1 shows the demographic, clinical characteristics, and
PCS/MCS scores between frail and non-frail patients. Of
168 respondents, 63 patients (37.5 %) were frail. Frail pa-
tients were significantly older than those who were non-frail
[t (166) = 2.67, p= .01]. Patients with hypertension etiology
of CKD experienced frailty more frequently than did those
with other etiologies (χ2 (1) = 3.85, p= .05). The mean scores
of PCS [t (88.0) = 8.77, p < .001] and MCS [t (84.18) = 5.44,
p < .001] were significantly lower in frail patients than they
were in non-frail patients, indicating that frail patients had
lower physical and mental quality of life. However, gender,
educational level, marital status, CKD stage, average income,
blood pressure, BUN, creatinine, and hemoglobin level were
not associated with frailty.
Influence of frailty on health-related quality of life
Table 2 presents the result of the hierarchical model evalu-
ating the influence of frailty on PCS and MCS. Model 1
predicted PCS [F (8, 155) = 2.98, p = .004], explaining
13.3 % of the variance in PCS scores. Older patients had
lower PCS than did younger patients after controlling for
covariates (p = .002). Model 2 was significantly improved
when frailty was included (R2 change = 29 %, p < .001),
explaining 42.3 % of the variance. Frailty was the only sig-
nificant predictor of PCS, indicating that frail patients had
lower PCS (p < .001). Table 3 reports the results of the hier-
archical model for MCS. The initial model did not predict
MCS (p = .306). Once frailty was included, however, the
second model was significantly improved (R2 change =
21.3 %, p < .001), explaining 27.1 % of the variance in MCS.
Age and frailty were significant predictors of MCS, indicat-
ing that younger patients (p = .005) and frail patients
(p < .001) had lower MCS after controlling for covariates.
Discussion
As compared to normative adults or patients with other
chronic diseases, CKD patients experience frailty more
frequently and have decreased quality of life. Little is
known about the influence of frailty on HRQOL for pre-
dialysis patients. Accordingly, the current study examined
the prevalence of frailty and the contribution of frailty
to HRQOL in pre-dialysis CKD patients in Korea. Our
study found that older age was associated with a higher
prevalence of frailty, which is consistent with other
studies [5, 8, 19]. We also found that the patients with
hypertensive etiology of CKD experienced frailty more
frequently. The mechanism underlying the relationship
between hypertension etiology and frailty is unclear,
but subclinical vascular disease, such as hypertension,
may contribute to the greater likelihood of frailty in pa-
tients with CKD [6]. Further, regardless of the etiology
of CKD, there was no difference in diastolic and sys-
tolic blood pressure between frail and non-frail groups,
which makes the influence of hypertension on frailty
inconclusive. Further studies are necessary to determine
the association between hypertension etiology and frailty
in pre-dialysis CKD patients.
Similar to another study [19], educational level and liv-
ing alone were not associated with frailty in the current
study. In contrast, there are inconsistent findings with
regard to the relation between gender and frailty. We
found that frailty was not different between men and
women, but female patients were found to be more frail
in other studies [8, 10]. This discordance may be due to
different sample characteristics. In Johansen’s study [10],
the study population was composed of hemodialysis pa-
tients, which may suggest that the influence of gender
on frailty depends on renal function. Although Mansur’s
[8] study and the current study included pre-dialysis pa-
tients, the relation between gender and frailty might be
explained by a third variable. In addition to gender, for
example, age might play a role in the relation with
frailty. In the current study, women were younger than
men were. The mean age in women and men was 62.5
and 67.8 years, respectively, and the proportions of older
age (≥60 years) in women and men were 54.8 % and
72.7 %, respectively (data not shown). Frailty increases
with age, such that aging is related to progressive
homeostatic dysregulation, which then leads to non-
resilient conditions [26]. It may be true that women are
more likely to be frail if the potential confounding factor
of age is taken into account. In our study, however, the
influence of gender on frailty might have weakened be-
cause age was not comparable between men and women.
Therefore, future studies are necessary to support the
relationship between gender, age, and frailty.
It has been consistently reported that CKD patients
who are older [5, 8, 19] and who have lower renal function
[3, 6, 7] are more vulnerable to frailty. Regarding the influ-
ence of age and renal function on frailty, the severity of
CKD might have a greater impact on frailty than age does.
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Renal function, age, and the prevalence of frailty differed
in the current study and Johansen’s study [10]. The preva-
lence of frailty was 67.7 % and 37.5 % in Johansen’s study
and the present study, respectively. Our study included
pre-dialysis patients with stages 2–4 CKD, while Johan-
sen’s study [10] targeted stage 5 dialysis patients, which
means that the renal function of the patients in our study
was better than it was in Johansen’s study. On the other
hand, the frail patients in our study were older than
were those in Johansen’s study (65.9 vs. 58.2 years old,
respectively), but the prevalence of frailty was lower in
the current study. Consequently, age influences frailty,
Table 1 Demographics, clinical characteristics, and physical/mental component scores (n = 168)
Frail (n = 63) Non-frail (n = 105) p
Mean (SD) Freq (%) Mean (SD) Freq (%)
Age 69.5 (13.9) 63.7 (13.5) .01
Gender
Male 35 (55.6) 71 (67.6) .12
Female 28 (44.4) 34 (32.4)
Education .28
≤ High school 43 (68.3) 63 (60.0)
> College 20 (31.7) 42 (40.0)
Marital status .33
Married 45 (71.4) 82 (78.1)
Other 18 (28.6) 23 (21.9)
CKD stage (mL/min/1.73 m2) 38.7 (14.1) 42.6 (16.8) .26
II (60–89) 6 (9.5) 18 (17.1)
III (30–59) 42 (66.7) 58 (55.2)
IV (15–29) 15 (23.8) 29 (27.6)
Employment status .10
Unemployed 44 (71.0) 61 (58.1)
Employed 18 (29.0) 44 (41.9)
Average income (10,000 won) .06
≤100 44 (72.1) 59 (57.3)
>101 17 (27.9) 44 (42.7)
Etiology of CKD
Diabetes 17 (27.0) 37 (35.2) .27
Hypertension 26 (41.3) 28 (26.7) .05
Glomerulonephritis 3 (4.8) 14 (13.3) .08
Unknown 24 (38.1) 32 (30.5) .31
Comorbidities
Diabetes 26 (41.3) 46 (43.8) .75
Hypertension 53 (84.1) 75 (71.4) .06
Cardiovascular disease 8 (12.7) 10 (9.5) .52
Blood pressure
Systolic 127.7 (16.8) 125.9 (13.3) .49
Diastolic 71.8 (13.0) 72.9 (10.6) .55
BUN 25.5 (9.5) 27.4 (10.8) .25
Creatinine 1.8 (.7) 1.8 (.7) .96
Hemoglobin 12.2 (1.9) 12.2 (2.0) .90
PCS 38.9 (9.6) 50.6 (5.5) < .001
MCS 44.1 (13.6) 54.2 (7.2) < .001
CKD Chronic Kidney Disease; PCS Physical Component Summary; MCS Mental Component Summary; BUN Blood Urea Nitrogen
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but renal function also greatly influences frailty in CKD
patients.
It is known that frailty is closely related to quality of
life, but few studies have examined the relationship
between frailty and quality of life simultaneously. Most
studies have reported the two concepts of frailty and
quality of life separately. We found that physical and
mental quality of life were significantly lower in frail
patients as compared to non-frail patients, which is
congruent with studies examining frailty and quality
of life in older adults [15] and in pre-dialysis CKD pa-
tients [8]. In hierarchical regression for the outcome
variable PCS, frailty significantly contributed to im-
provement of the model. After adjusting for the covar-
iates, the variance increased when frailty was included,
indicating that frailty greatly influences physical health
in pre-dialysis CKD patients. Age might also influence
physical HRQOL. In the initial model without frailty,
old age predicted worse PCS, which is consistent with
other studies [21, 22]. After frailty was included in the
first model, however, age was no longer significant,
and only frailty predicted PCS, indicating that frail pa-
tients had lower PCS. This finding may support the
claim that the influence of frailty on PCS is critical,
and that frailty is an independent, significant predictor
over age.
Frailty was also related to decreased mental quality of
life. When frailty was included into the initial model, the
variance of MCS increased and age became significant,
indicating that younger patients had lower MCS. On the
other hand, other studies [21, 23] showed inconsistent
results indicating a relationship between older age and
lower MCS. The concept of frailty was only included in
the current study, whereas frailty was not measured in
the other two studies. Thus, it appears that frailty con-
tributes to this discrepancy, indicating that there may be
an interaction between frailty and age on MCS. In the
subgroup analysis (data not shown), younger patients
(age < 60 years) had lower MCS than older patients
(age ≥ 60 years), regardless of frailty. Regarding age
group and frailty, the MCS scores were as follows: 42.58
in the young frail group, 44.67 in the old frail group,
50.41 in the young non-frail group, and 56.28 in the old
non-frail group. Thus, MCS scores were lowest in the
young frail group. The score of 42.58 in the young frail
group was lower than that found in stage 4 CKD pa-
tients [22]. Further, participants’ age and renal function
might contribute to this discrepancy. The mean age of
participants in our study was 65.9 years, while the pa-
tients in other studies were relatively younger, namely,
51.7 years [23] and 54.4 years [21]. The study partici-
pants in the two studies also had more advanced renal
condition in terms of pre-dialysis vs. dialysis patients,
indicating that disease severity may be associated with
mental quality of life.
There are several weaknesses of the current study.
First, the cross-sectional study design limits the ability
to determine causal relationships. Additionally, the findings
may not be generalizable to pre-dialysis CKD patients not
included in this study. In addition, cognitive impairment of
Table 2 Hierarchical regression of the influence of frailty on PCS
Predictors β t p
Model 1 (R2 = .133,
p = .004)
Female -.155 −1.749 .082
Age -.265 −3.101 .002
College graduate .027 .330 .742
Living with spouse .108 1.328 .186
Diabetes (Yes) -.060 -.762 .447
Hypertension (Yes) -.088 −1.124 .263
Employed -.020 -.239 .812
eGFR (mL/min/1.73 m2) .063 .759 .449
Model 2(R2 = .423, R2
change = .29, p < .001)
Female -.063 -.859 .392
Age -.124 −1.732 .085
College graduate .021 .312 .756
Living with spouse .081 1.219 .225
Diabetes (Yes) -.079 −1.225 .222
Hypertension (Yes) -.030 -.469 .640
Employed .051 .757 .450
eGFR (mL/min/1.73 m2) .040 .590 .556
Frailty (Yes) -.566 −8.792 < .001
PCS Physical Component Summary; eGFR Estimated Glomerular Filtration Rate
Table 3 Hierarchical regression of the influence of frailty on MCS
Predictors β t p
Model 1(R2 = .058,
p = .306)
Female -.026 -.285 .776
Age .108 1.213 .227
College graduate .015 -.176 .861
Living with spouse .165 1.980 .053
Diabetes (Yes) .011 .134 .894
Hypertension (Yes) .022 .264 .792
Employed -.043 -.507 .613
eGFR (mL/min/1.73 m2) .115 1.340 .182
Model 2(R2 = .271, R2
change = .213, p < .001)
Female .053 .638 .524
Age .228 2.836 .005
College graduate -.020 -.269 .789
Living with spouse .142 1.901 .059
Diabetes (Yes) -.005 -.074 .941
Hypertension (Yes) .071 .983 .327
Employed .017 .228 .820
eGFR (mL/min/1.73 m2) .096 1.261 .209
Frailty (Yes) -.485 −6.709 < .001
MCS Mental Component Summary; eGFR Estimated Glomerular Filtration Rate
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the patients was assessed by the physician and research
assistant. Although the assessment was done by the
professional and the interviewer in two steps, it may
still be possible that the screening was biased as opposed
to using a valid assessment instrument measuring cogni-
tive impairment. Despite these limitations, our study high-
lights the significant contribution of frailty to HRQOL in
CKD patients. Although pre-dialysis patients have a better
quality of life compared to those on dialysis, they have still
have a lower quality of life than those without CKD or
patients with other chronic diseases [27].
We found that frail patients had lower HRQOL than
did non-frail patients. In particular, as MCS decreases,
repeated psychological distress occurs, which leads to
impaired homeostatic equilibrium and emergence of
disease [28]. Given that CKD is a lifelong disease, it is
important for pre-dialysis CKD patients to provide in-
terventions that increase quality of life. For example, a
nutrition intervention improved quality of life in pre-
dialysis CKD patients [29]. Various factors, including
inflammatory factors, hormone changes, malnutrition,
anemia, and depression, have been known to influence
the occurrence of frailty [30, 31]. As a high proportion
of CKD patients experience frailty that influences
long-term quality of life, early frailty detection and
preventive intervention programs are necessary to im-
prove quality of life. Exercise training for pre-dialysis
CKD patients improved physical impairment and
health-related quality of life [32], which could be a
good example.
Conclusions
The present study showed that frailty influenced both
physical and mental quality of life in pre-dialysis patients
with CKD in Korea. More attention should be paid to
the potential role of early detection and prevention of
frailty to improve patients’ quality of life. Further studies
are necessary to develop effective interventions to ad-
dress modifiable factors influencing frailty and quality of
life among patients with CKD.
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